Abstract

Background and AimsCeliac sprue is a life-long disease characterized by an intestinal inflammatory response to dietary gluten. A gluten-free diet is an effective treatment for most patients, but accidental ingestion of gluten is common, leading to incomplete recovery or relapse. Food-grade proteases capable of detoxifying moderate quantities of dietary gluten could mitigate this problem.MethodsWe evaluated the gluten detoxification properties of two food-grade enzymes, aspergillopepsin (ASP) from Aspergillus niger and dipeptidyl peptidase IV (DPPIV) from Aspergillus oryzae. The ability of each enzyme to hydrolyze gluten was tested against synthetic gluten peptides, a recombinant gluten protein, and simulated gastric digests of whole gluten and whole-wheat bread. Reaction products were analyzed by mass spectrometry, HPLC, ELISA with a monoclonal antibody that recognizes an immunodominant gluten epitope, and a T cell proliferation assay.ResultsASP markedly enhanced gluten digestion relative to pepsin, and cleaved recombinant α2-gliadin at multiple sites in a non-specific manner. When used alone, neither ASP nor DPPIV efficiently cleaved synthetic immunotoxic gluten peptides. This lack of specificity for gluten was especially evident in the presence of casein, a competing dietary protein. However, supplementation of ASP with DPPIV enabled detoxification of moderate amounts of gluten in the presence of excess casein and in whole-wheat bread. ASP was also effective at enhancing the gluten-detoxifying efficacy of cysteine endoprotease EP-B2 under simulated gastric conditions.ConclusionsClinical studies are warranted to evaluate whether a fixed dose ratio combination of ASP and DPPIV can provide near-term relief for celiac patients suffering from inadvertent gluten exposure. Due to its markedly greater hydrolytic activity against gluten than endogenous pepsin, food-grade ASP may also augment the activity of therapeutically relevant doses of glutenases such as EP-B2 and certain prolyl endopeptidases.

Highlights

  • Celiac sprue is an inheritable, life-long disease that is characterized by an inflammatory reaction to dietary gluten in the human small intestine

  • The Materials Safety Data Sheet of the commercial Peptidase P powder from Bio-Cat Inc. designates this enzyme as dipeptidyl peptidase IV from A. oryzae (EC 3.4.21.63)

  • dipeptidyl peptidase IV (DPPIV) activity could be verified by the chromogenic substrate Gly-PropNA, SDS-PAGE revealed that the enzyme preparation was a complex mixture of proteins that lacked a prominent band with MW higher than 75 kD, as might be expected for this DPPIV [8]

Read more

Summary

Introduction

Celiac sprue is an inheritable, life-long disease that is characterized by an inflammatory reaction to dietary gluten in the human small intestine. Celiac sprue is associated with complications such as anemia, bone diseases, infertility, neurological problems, cancer and other complications due to persistent inflammation and micronutrient deficiencies. The only suitable treatment is strict, life-long exclusion of gluten from the patient’s diet. A large fraction of patients who attempt to follow such a diet still exhibit signs or symptoms of active disease [2,3,4,5], there is no available supplementary therapy for such conditions. Celiac sprue is a life-long disease characterized by an intestinal inflammatory response to dietary gluten. Food-grade proteases capable of detoxifying moderate quantities of dietary gluten could mitigate this problem

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call